Aclaris Therapeutics to Showcase Innovations at Major Conference
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focusing on groundbreaking treatments for immuno-inflammatory diseases, announced an exciting opportunity to engage with investors and the public. The management team is set to participate in a fireside chat during the highly regarded Piper Sandler 36th Annual Healthcare Conference.
Details of the Conference Participation
This significant event will take place on a specified date in the city known for its dynamic healthcare market, where Aclaris will present its vision and ongoing projects. The members of the Aclaris team look forward to discussing their innovative pipeline aimed at addressing unmet medical needs within the immuno-inflammatory disease space.
Accessing the Webcast
For those interested in tuning into the discussion, a webcast will be available via the "Events" page in the "Investors" section of Aclaris' website. This feature will allow audiences to witness the dialogue and insights shared during the conference, with availability for an extended period post-event.
Understanding Aclaris Therapeutics
At its core, Aclaris Therapeutics is dedicated to crafting novel therapeutic solutions for conditions where existing treatments fall short. The company is proud of its strong research and development capabilities focused on protein kinase regulation, which forms the foundation of its drug candidate portfolio.
Contacting Aclaris Therapeutics
For further inquiries or more detailed information regarding Aclaris Therapeutics' initiatives and innovations, interested parties may contact the company directly. They welcome communication to ensure stakeholders are well-informed about their progress and contributions to the healthcare industry.
Frequently Asked Questions
What is Aclaris Therapeutics known for?
Aclaris Therapeutics is renowned for developing innovative drug candidates for immuno-inflammatory diseases.
When will Aclaris participate in the healthcare conference?
The company will take part in the Piper Sandler Annual Healthcare Conference, with specific timing available on their website.
How can I access the conference webcast?
The webcast will be accessible through the "Events" page in the "Investors" section of Aclaris' website.
What is the focus of Aclaris' research?
Aclaris focuses on addressing unmet needs in immuno-inflammatory diseases, utilizing advanced protein kinase regulation research.
Who can I contact for more information?
For inquiries, you can reach out via the contact email listed on Aclaris Therapeutics’ website.